{"schema":"qazvision-content-revisions/v1","entity":{"type":"atom","code":"AKR-2025-0929-GLAVANAGRA-F-004","history_url":"https://qaz.vision/api/revisions/atom/AKR-2025-0929-GLAVANAGRA-F-004.json"},"verification":{"hash_algorithm":"sha256","chain":"previous_hash points to the preceding content_hash for this entity","payload_included":false},"revision_count":2,"limit":20,"current":{"id":18021,"entity_type":"atom","entity_id":5550,"entity_code":"AKR-2025-0929-GLAVANAGRA-F-004","revision_number":2,"operation":"baseline","public_state":"published","content_hash":"cd1321f5586932a26f436cc2785655828d11de328ed836ed0ec6ac9744203ea8","previous_hash":"16a4172f290003c3726394082c18eb6acc99f1360686d821ca5e28e0e4f8d0cd","created_at":"2026-07-14T05:09:38.243695Z","canonical_url":"https://qaz.vision/dokument/875"},"revisions":[{"id":18021,"entity_type":"atom","entity_id":5550,"entity_code":"AKR-2025-0929-GLAVANAGRA-F-004","revision_number":2,"operation":"baseline","public_state":"published","content_hash":"cd1321f5586932a26f436cc2785655828d11de328ed836ed0ec6ac9744203ea8","previous_hash":"16a4172f290003c3726394082c18eb6acc99f1360686d821ca5e28e0e4f8d0cd","created_at":"2026-07-14T05:09:38.243695Z","canonical_url":"https://qaz.vision/dokument/875"},{"id":7452,"entity_type":"atom","entity_id":5550,"entity_code":"AKR-2025-0929-GLAVANAGRA-F-004","revision_number":1,"operation":"baseline","public_state":"published","content_hash":"16a4172f290003c3726394082c18eb6acc99f1360686d821ca5e28e0e4f8d0cd","previous_hash":null,"created_at":"2026-07-13T18:08:53.580859Z","canonical_url":"https://qaz.vision/dokument/875"}]}